nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A8—Mycophenolate mofetil—systemic scleroderma	0.287	0.363	CbGbCtD
Morphine—UGT2B7—Mycophenolic acid—systemic scleroderma	0.122	0.155	CbGbCtD
Morphine—UGT1A1—Mycophenolic acid—systemic scleroderma	0.106	0.134	CbGbCtD
Morphine—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0684	0.0865	CbGbCtD
Morphine—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0591	0.0748	CbGbCtD
Morphine—CYP2C8—Mometasone—systemic scleroderma	0.0435	0.055	CbGbCtD
Morphine—ABCB1—Lisinopril—systemic scleroderma	0.0199	0.0252	CbGbCtD
Morphine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0173	0.0219	CbGbCtD
Morphine—ABCB1—Captopril—systemic scleroderma	0.0149	0.0188	CbGbCtD
Morphine—CYP2D6—Captopril—systemic scleroderma	0.014	0.0177	CbGbCtD
Morphine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0117	0.0148	CbGbCtD
Morphine—ABCB1—Prednisone—systemic scleroderma	0.00937	0.0119	CbGbCtD
Morphine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00702	0.00888	CbGbCtD
Morphine—CYP3A4—Prednisone—systemic scleroderma	0.00561	0.0071	CbGbCtD
Morphine—ABCB1—Methotrexate—systemic scleroderma	0.0047	0.00595	CbGbCtD
Morphine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000125	0.000594	CcSEcCtD
Morphine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000125	0.000594	CcSEcCtD
Morphine—Mood swings—Methotrexate—systemic scleroderma	0.000124	0.000593	CcSEcCtD
Morphine—Nausea—Mometasone—systemic scleroderma	0.000124	0.000592	CcSEcCtD
Morphine—Anorexia—Lisinopril—systemic scleroderma	0.000124	0.000591	CcSEcCtD
Morphine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000124	0.00059	CcSEcCtD
Morphine—Ataxia—Methotrexate—systemic scleroderma	0.000124	0.000589	CcSEcCtD
Morphine—Pain—Mycophenolic acid—systemic scleroderma	0.000124	0.000589	CcSEcCtD
Morphine—Constipation—Mycophenolic acid—systemic scleroderma	0.000124	0.000589	CcSEcCtD
Morphine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000588	CcSEcCtD
Morphine—Weight decreased—Prednisone—systemic scleroderma	0.000123	0.000586	CcSEcCtD
Morphine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000585	CcSEcCtD
Morphine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000123	0.000584	CcSEcCtD
Morphine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000581	CcSEcCtD
Morphine—Hypotension—Lisinopril—systemic scleroderma	0.000122	0.000579	CcSEcCtD
Morphine—Dizziness—Captopril—systemic scleroderma	0.000121	0.000579	CcSEcCtD
Morphine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000121	0.000578	CcSEcCtD
Morphine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000577	CcSEcCtD
Morphine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000575	CcSEcCtD
Morphine—Urticaria—Leflunomide—systemic scleroderma	0.00012	0.000573	CcSEcCtD
Morphine—Abdominal pain—Leflunomide—systemic scleroderma	0.00012	0.000571	CcSEcCtD
Morphine—Body temperature increased—Leflunomide—systemic scleroderma	0.00012	0.000571	CcSEcCtD
Morphine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000119	0.000567	CcSEcCtD
Morphine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000567	CcSEcCtD
Morphine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000567	CcSEcCtD
Morphine—Breast disorder—Methotrexate—systemic scleroderma	0.000119	0.000566	CcSEcCtD
Morphine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000119	0.000565	CcSEcCtD
Morphine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000565	CcSEcCtD
Morphine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000118	0.000563	CcSEcCtD
Morphine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000118	0.000563	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000563	CcSEcCtD
Morphine—Insomnia—Lisinopril—systemic scleroderma	0.000118	0.000561	CcSEcCtD
Morphine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000117	0.00056	CcSEcCtD
Morphine—Paraesthesia—Lisinopril—systemic scleroderma	0.000117	0.000557	CcSEcCtD
Morphine—Vomiting—Captopril—systemic scleroderma	0.000117	0.000557	CcSEcCtD
Morphine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000554	CcSEcCtD
Morphine—Dyspnoea—Lisinopril—systemic scleroderma	0.000116	0.000553	CcSEcCtD
Morphine—Rash—Captopril—systemic scleroderma	0.000116	0.000552	CcSEcCtD
Morphine—Dermatitis—Captopril—systemic scleroderma	0.000116	0.000552	CcSEcCtD
Morphine—Somnolence—Lisinopril—systemic scleroderma	0.000116	0.000551	CcSEcCtD
Morphine—Headache—Captopril—systemic scleroderma	0.000115	0.000549	CcSEcCtD
Morphine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000548	CcSEcCtD
Morphine—Dyspepsia—Lisinopril—systemic scleroderma	0.000115	0.000546	CcSEcCtD
Morphine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000114	0.000544	CcSEcCtD
Morphine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000114	0.000544	CcSEcCtD
Morphine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000543	CcSEcCtD
Morphine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000543	CcSEcCtD
Morphine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000113	0.00054	CcSEcCtD
Morphine—Decreased appetite—Lisinopril—systemic scleroderma	0.000113	0.000539	CcSEcCtD
Morphine—Eosinophilia—Methotrexate—systemic scleroderma	0.000112	0.000536	CcSEcCtD
Morphine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000112	0.000535	CcSEcCtD
Morphine—Fatigue—Lisinopril—systemic scleroderma	0.000112	0.000535	CcSEcCtD
Morphine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000535	CcSEcCtD
Morphine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000533	CcSEcCtD
Morphine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000532	CcSEcCtD
Morphine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000112	0.000532	CcSEcCtD
Morphine—Pain—Lisinopril—systemic scleroderma	0.000111	0.00053	CcSEcCtD
Morphine—Constipation—Lisinopril—systemic scleroderma	0.000111	0.00053	CcSEcCtD
Morphine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00053	CcSEcCtD
Morphine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000528	CcSEcCtD
Morphine—Bradycardia—Prednisone—systemic scleroderma	0.000111	0.000528	CcSEcCtD
Morphine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000525	CcSEcCtD
Morphine—Diarrhoea—Azathioprine—systemic scleroderma	0.00011	0.000523	CcSEcCtD
Morphine—Nausea—Captopril—systemic scleroderma	0.000109	0.00052	CcSEcCtD
Morphine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000518	CcSEcCtD
Morphine—Asthenia—Leflunomide—systemic scleroderma	0.000109	0.000518	CcSEcCtD
Morphine—Hallucination—Prednisone—systemic scleroderma	0.000108	0.000516	CcSEcCtD
Morphine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000107	0.000511	CcSEcCtD
Morphine—Pruritus—Leflunomide—systemic scleroderma	0.000107	0.000511	CcSEcCtD
Morphine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000107	0.000509	CcSEcCtD
Morphine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000508	CcSEcCtD
Morphine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000106	0.000507	CcSEcCtD
Morphine—Dysuria—Methotrexate—systemic scleroderma	0.000106	0.000506	CcSEcCtD
Morphine—Dizziness—Azathioprine—systemic scleroderma	0.000106	0.000505	CcSEcCtD
Morphine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000105	0.000499	CcSEcCtD
Morphine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000495	CcSEcCtD
Morphine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000104	0.000494	CcSEcCtD
Morphine—Diarrhoea—Leflunomide—systemic scleroderma	0.000104	0.000494	CcSEcCtD
Morphine—Urticaria—Lisinopril—systemic scleroderma	0.000103	0.000493	CcSEcCtD
Morphine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000491	CcSEcCtD
Morphine—Abdominal pain—Lisinopril—systemic scleroderma	0.000103	0.00049	CcSEcCtD
Morphine—Body temperature increased—Lisinopril—systemic scleroderma	0.000103	0.00049	CcSEcCtD
Morphine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000488	CcSEcCtD
Morphine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000102	0.000487	CcSEcCtD
Morphine—Vomiting—Azathioprine—systemic scleroderma	0.000102	0.000486	CcSEcCtD
Morphine—Eye disorder—Prednisone—systemic scleroderma	0.000102	0.000484	CcSEcCtD
Morphine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000484	CcSEcCtD
Morphine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000483	CcSEcCtD
Morphine—Drowsiness—Methotrexate—systemic scleroderma	0.000101	0.000483	CcSEcCtD
Morphine—Rash—Azathioprine—systemic scleroderma	0.000101	0.000482	CcSEcCtD
Morphine—Dermatitis—Azathioprine—systemic scleroderma	0.000101	0.000481	CcSEcCtD
Morphine—Flushing—Prednisone—systemic scleroderma	0.000101	0.000481	CcSEcCtD
Morphine—Headache—Azathioprine—systemic scleroderma	0.0001	0.000479	CcSEcCtD
Morphine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000478	CcSEcCtD
Morphine—Dizziness—Leflunomide—systemic scleroderma	0.0001	0.000477	CcSEcCtD
Morphine—Renal failure—Methotrexate—systemic scleroderma	9.95e-05	0.000474	CcSEcCtD
Morphine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	9.91e-05	0.000472	CcSEcCtD
Morphine—Diarrhoea—Mycophenolic acid—systemic scleroderma	9.88e-05	0.000471	CcSEcCtD
Morphine—Stomatitis—Methotrexate—systemic scleroderma	9.87e-05	0.00047	CcSEcCtD
Morphine—Angiopathy—Prednisone—systemic scleroderma	9.87e-05	0.00047	CcSEcCtD
Morphine—Conjunctivitis—Methotrexate—systemic scleroderma	9.84e-05	0.000469	CcSEcCtD
Morphine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	9.84e-05	0.000469	CcSEcCtD
Morphine—Constipation—Mycophenolate mofetil—systemic scleroderma	9.75e-05	0.000465	CcSEcCtD
Morphine—Pain—Mycophenolate mofetil—systemic scleroderma	9.75e-05	0.000465	CcSEcCtD
Morphine—Sweating—Methotrexate—systemic scleroderma	9.71e-05	0.000463	CcSEcCtD
Morphine—Vomiting—Leflunomide—systemic scleroderma	9.63e-05	0.000459	CcSEcCtD
Morphine—Hypersensitivity—Lisinopril—systemic scleroderma	9.59e-05	0.000457	CcSEcCtD
Morphine—Hepatobiliary disease—Methotrexate—systemic scleroderma	9.58e-05	0.000456	CcSEcCtD
Morphine—Dizziness—Mycophenolic acid—systemic scleroderma	9.55e-05	0.000455	CcSEcCtD
Morphine—Rash—Leflunomide—systemic scleroderma	9.55e-05	0.000455	CcSEcCtD
Morphine—Dermatitis—Leflunomide—systemic scleroderma	9.54e-05	0.000455	CcSEcCtD
Morphine—Mental disorder—Prednisone—systemic scleroderma	9.53e-05	0.000454	CcSEcCtD
Morphine—Nausea—Azathioprine—systemic scleroderma	9.52e-05	0.000454	CcSEcCtD
Morphine—Headache—Leflunomide—systemic scleroderma	9.49e-05	0.000452	CcSEcCtD
Morphine—Erythema—Prednisone—systemic scleroderma	9.47e-05	0.000451	CcSEcCtD
Morphine—Malnutrition—Prednisone—systemic scleroderma	9.47e-05	0.000451	CcSEcCtD
Morphine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	9.39e-05	0.000448	CcSEcCtD
Morphine—Asthenia—Lisinopril—systemic scleroderma	9.33e-05	0.000445	CcSEcCtD
Morphine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	9.32e-05	0.000444	CcSEcCtD
Morphine—Pruritus—Lisinopril—systemic scleroderma	9.2e-05	0.000439	CcSEcCtD
Morphine—Vomiting—Mycophenolic acid—systemic scleroderma	9.18e-05	0.000438	CcSEcCtD
Morphine—Rash—Mycophenolic acid—systemic scleroderma	9.11e-05	0.000434	CcSEcCtD
Morphine—Dermatitis—Mycophenolic acid—systemic scleroderma	9.1e-05	0.000434	CcSEcCtD
Morphine—Hepatitis—Methotrexate—systemic scleroderma	9.09e-05	0.000433	CcSEcCtD
Morphine—Urticaria—Mycophenolate mofetil—systemic scleroderma	9.06e-05	0.000432	CcSEcCtD
Morphine—Headache—Mycophenolic acid—systemic scleroderma	9.05e-05	0.000431	CcSEcCtD
Morphine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	9.01e-05	0.00043	CcSEcCtD
Morphine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	9.01e-05	0.00043	CcSEcCtD
Morphine—Nausea—Leflunomide—systemic scleroderma	8.99e-05	0.000429	CcSEcCtD
Morphine—Urinary tract disorder—Methotrexate—systemic scleroderma	8.98e-05	0.000428	CcSEcCtD
Morphine—Vision blurred—Prednisone—systemic scleroderma	8.92e-05	0.000425	CcSEcCtD
Morphine—Urethral disorder—Methotrexate—systemic scleroderma	8.91e-05	0.000425	CcSEcCtD
Morphine—Diarrhoea—Lisinopril—systemic scleroderma	8.9e-05	0.000424	CcSEcCtD
Morphine—Ill-defined disorder—Prednisone—systemic scleroderma	8.78e-05	0.000419	CcSEcCtD
Morphine—Visual impairment—Methotrexate—systemic scleroderma	8.76e-05	0.000418	CcSEcCtD
Morphine—Anaemia—Prednisone—systemic scleroderma	8.75e-05	0.000417	CcSEcCtD
Morphine—Agitation—Prednisone—systemic scleroderma	8.7e-05	0.000415	CcSEcCtD
Morphine—Dizziness—Lisinopril—systemic scleroderma	8.6e-05	0.00041	CcSEcCtD
Morphine—Nausea—Mycophenolic acid—systemic scleroderma	8.58e-05	0.000409	CcSEcCtD
Morphine—Malaise—Prednisone—systemic scleroderma	8.54e-05	0.000407	CcSEcCtD
Morphine—Vertigo—Prednisone—systemic scleroderma	8.51e-05	0.000405	CcSEcCtD
Morphine—Eye disorder—Methotrexate—systemic scleroderma	8.49e-05	0.000405	CcSEcCtD
Morphine—Syncope—Prednisone—systemic scleroderma	8.49e-05	0.000405	CcSEcCtD
Morphine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	8.4e-05	0.0004	CcSEcCtD
Morphine—Loss of consciousness—Prednisone—systemic scleroderma	8.32e-05	0.000397	CcSEcCtD
Morphine—Vomiting—Lisinopril—systemic scleroderma	8.27e-05	0.000394	CcSEcCtD
Morphine—Angiopathy—Methotrexate—systemic scleroderma	8.25e-05	0.000393	CcSEcCtD
Morphine—Rash—Lisinopril—systemic scleroderma	8.2e-05	0.000391	CcSEcCtD
Morphine—Convulsion—Prednisone—systemic scleroderma	8.2e-05	0.000391	CcSEcCtD
Morphine—Dermatitis—Lisinopril—systemic scleroderma	8.2e-05	0.000391	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—systemic scleroderma	8.19e-05	0.00039	CcSEcCtD
Morphine—Asthenia—Mycophenolate mofetil—systemic scleroderma	8.18e-05	0.00039	CcSEcCtD
Morphine—Hypertension—Prednisone—systemic scleroderma	8.17e-05	0.00039	CcSEcCtD
Morphine—Chills—Methotrexate—systemic scleroderma	8.16e-05	0.000389	CcSEcCtD
Morphine—Headache—Lisinopril—systemic scleroderma	8.15e-05	0.000388	CcSEcCtD
Morphine—Pruritus—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.000384	CcSEcCtD
Morphine—Arthralgia—Prednisone—systemic scleroderma	8.06e-05	0.000384	CcSEcCtD
Morphine—Anxiety—Prednisone—systemic scleroderma	8.03e-05	0.000383	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	8e-05	0.000382	CcSEcCtD
Morphine—Discomfort—Prednisone—systemic scleroderma	7.96e-05	0.00038	CcSEcCtD
Morphine—Mental disorder—Methotrexate—systemic scleroderma	7.96e-05	0.00038	CcSEcCtD
Morphine—Erythema—Methotrexate—systemic scleroderma	7.91e-05	0.000377	CcSEcCtD
Morphine—Malnutrition—Methotrexate—systemic scleroderma	7.91e-05	0.000377	CcSEcCtD
Morphine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	7.8e-05	0.000372	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—systemic scleroderma	7.75e-05	0.000369	CcSEcCtD
Morphine—Nausea—Lisinopril—systemic scleroderma	7.73e-05	0.000368	CcSEcCtD
Morphine—Oedema—Prednisone—systemic scleroderma	7.73e-05	0.000368	CcSEcCtD
Morphine—Anaphylactic shock—Prednisone—systemic scleroderma	7.73e-05	0.000368	CcSEcCtD
Morphine—Infection—Prednisone—systemic scleroderma	7.68e-05	0.000366	CcSEcCtD
Morphine—Back pain—Methotrexate—systemic scleroderma	7.65e-05	0.000365	CcSEcCtD
Morphine—Shock—Prednisone—systemic scleroderma	7.6e-05	0.000362	CcSEcCtD
Morphine—Nervous system disorder—Prednisone—systemic scleroderma	7.58e-05	0.000361	CcSEcCtD
Morphine—Tachycardia—Prednisone—systemic scleroderma	7.54e-05	0.000359	CcSEcCtD
Morphine—Dizziness—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.000359	CcSEcCtD
Morphine—Skin disorder—Prednisone—systemic scleroderma	7.51e-05	0.000358	CcSEcCtD
Morphine—Hyperhidrosis—Prednisone—systemic scleroderma	7.47e-05	0.000356	CcSEcCtD
Morphine—Vision blurred—Methotrexate—systemic scleroderma	7.46e-05	0.000355	CcSEcCtD
Morphine—Anorexia—Prednisone—systemic scleroderma	7.37e-05	0.000351	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—systemic scleroderma	7.34e-05	0.00035	CcSEcCtD
Morphine—Anaemia—Methotrexate—systemic scleroderma	7.31e-05	0.000349	CcSEcCtD
Morphine—Vomiting—Mycophenolate mofetil—systemic scleroderma	7.25e-05	0.000345	CcSEcCtD
Morphine—Rash—Mycophenolate mofetil—systemic scleroderma	7.19e-05	0.000343	CcSEcCtD
Morphine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	7.18e-05	0.000342	CcSEcCtD
Morphine—Headache—Mycophenolate mofetil—systemic scleroderma	7.14e-05	0.00034	CcSEcCtD
Morphine—Malaise—Methotrexate—systemic scleroderma	7.14e-05	0.00034	CcSEcCtD
Morphine—Vertigo—Methotrexate—systemic scleroderma	7.11e-05	0.000339	CcSEcCtD
Morphine—Leukopenia—Methotrexate—systemic scleroderma	7.08e-05	0.000338	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	7.04e-05	0.000336	CcSEcCtD
Morphine—Insomnia—Prednisone—systemic scleroderma	6.99e-05	0.000333	CcSEcCtD
Morphine—Paraesthesia—Prednisone—systemic scleroderma	6.94e-05	0.000331	CcSEcCtD
Morphine—Cough—Methotrexate—systemic scleroderma	6.9e-05	0.000329	CcSEcCtD
Morphine—Convulsion—Methotrexate—systemic scleroderma	6.86e-05	0.000327	CcSEcCtD
Morphine—Dyspepsia—Prednisone—systemic scleroderma	6.8e-05	0.000324	CcSEcCtD
Morphine—Nausea—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.000323	CcSEcCtD
Morphine—Chest pain—Methotrexate—systemic scleroderma	6.74e-05	0.000321	CcSEcCtD
Morphine—Arthralgia—Methotrexate—systemic scleroderma	6.74e-05	0.000321	CcSEcCtD
Morphine—Decreased appetite—Prednisone—systemic scleroderma	6.72e-05	0.00032	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	6.69e-05	0.000319	CcSEcCtD
Morphine—Fatigue—Prednisone—systemic scleroderma	6.66e-05	0.000318	CcSEcCtD
Morphine—Discomfort—Methotrexate—systemic scleroderma	6.66e-05	0.000317	CcSEcCtD
Morphine—Constipation—Prednisone—systemic scleroderma	6.61e-05	0.000315	CcSEcCtD
Morphine—Confusional state—Methotrexate—systemic scleroderma	6.51e-05	0.00031	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—systemic scleroderma	6.46e-05	0.000308	CcSEcCtD
Morphine—Infection—Methotrexate—systemic scleroderma	6.42e-05	0.000306	CcSEcCtD
Morphine—Feeling abnormal—Prednisone—systemic scleroderma	6.37e-05	0.000304	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—systemic scleroderma	6.33e-05	0.000302	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—systemic scleroderma	6.32e-05	0.000301	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—systemic scleroderma	6.32e-05	0.000301	CcSEcCtD
Morphine—Skin disorder—Methotrexate—systemic scleroderma	6.27e-05	0.000299	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—systemic scleroderma	6.24e-05	0.000298	CcSEcCtD
Morphine—Anorexia—Methotrexate—systemic scleroderma	6.16e-05	0.000293	CcSEcCtD
Morphine—Urticaria—Prednisone—systemic scleroderma	6.14e-05	0.000293	CcSEcCtD
Morphine—Abdominal pain—Prednisone—systemic scleroderma	6.11e-05	0.000291	CcSEcCtD
Morphine—Body temperature increased—Prednisone—systemic scleroderma	6.11e-05	0.000291	CcSEcCtD
Morphine—Hypotension—Methotrexate—systemic scleroderma	6.03e-05	0.000288	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.88e-05	0.00028	CcSEcCtD
Morphine—Insomnia—Methotrexate—systemic scleroderma	5.84e-05	0.000278	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—systemic scleroderma	5.8e-05	0.000276	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—systemic scleroderma	5.76e-05	0.000274	CcSEcCtD
Morphine—Somnolence—Methotrexate—systemic scleroderma	5.74e-05	0.000274	CcSEcCtD
Morphine—Hypersensitivity—Prednisone—systemic scleroderma	5.69e-05	0.000271	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—systemic scleroderma	5.68e-05	0.000271	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—systemic scleroderma	5.61e-05	0.000268	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	5.57e-05	0.000266	CcSEcCtD
Morphine—Fatigue—Methotrexate—systemic scleroderma	5.57e-05	0.000265	CcSEcCtD
Morphine—Asthenia—Prednisone—systemic scleroderma	5.54e-05	0.000264	CcSEcCtD
Morphine—Pain—Methotrexate—systemic scleroderma	5.52e-05	0.000263	CcSEcCtD
Morphine—Pruritus—Prednisone—systemic scleroderma	5.47e-05	0.000261	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—systemic scleroderma	5.32e-05	0.000254	CcSEcCtD
Morphine—Diarrhoea—Prednisone—systemic scleroderma	5.29e-05	0.000252	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—systemic scleroderma	5.28e-05	0.000252	CcSEcCtD
Morphine—Urticaria—Methotrexate—systemic scleroderma	5.13e-05	0.000245	CcSEcCtD
Morphine—Dizziness—Prednisone—systemic scleroderma	5.11e-05	0.000244	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—systemic scleroderma	5.1e-05	0.000243	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—systemic scleroderma	5.1e-05	0.000243	CcSEcCtD
Morphine—Vomiting—Prednisone—systemic scleroderma	4.91e-05	0.000234	CcSEcCtD
Morphine—Rash—Prednisone—systemic scleroderma	4.87e-05	0.000232	CcSEcCtD
Morphine—Dermatitis—Prednisone—systemic scleroderma	4.87e-05	0.000232	CcSEcCtD
Morphine—Headache—Prednisone—systemic scleroderma	4.84e-05	0.000231	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—systemic scleroderma	4.76e-05	0.000227	CcSEcCtD
Morphine—Asthenia—Methotrexate—systemic scleroderma	4.63e-05	0.000221	CcSEcCtD
Morphine—Nausea—Prednisone—systemic scleroderma	4.59e-05	0.000219	CcSEcCtD
Morphine—Pruritus—Methotrexate—systemic scleroderma	4.57e-05	0.000218	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—systemic scleroderma	4.42e-05	0.000211	CcSEcCtD
Morphine—Dizziness—Methotrexate—systemic scleroderma	4.27e-05	0.000204	CcSEcCtD
Morphine—Vomiting—Methotrexate—systemic scleroderma	4.11e-05	0.000196	CcSEcCtD
Morphine—Rash—Methotrexate—systemic scleroderma	4.07e-05	0.000194	CcSEcCtD
Morphine—Dermatitis—Methotrexate—systemic scleroderma	4.07e-05	0.000194	CcSEcCtD
Morphine—Headache—Methotrexate—systemic scleroderma	4.05e-05	0.000193	CcSEcCtD
Morphine—Nausea—Methotrexate—systemic scleroderma	3.84e-05	0.000183	CcSEcCtD
